1. Home
  2. ONMD vs COEP Comparison

ONMD vs COEP Comparison

Compare ONMD & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • COEP
  • Stock Information
  • Founded
  • ONMD 2006
  • COEP 2017
  • Country
  • ONMD United States
  • COEP United States
  • Employees
  • ONMD N/A
  • COEP N/A
  • Industry
  • ONMD
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ONMD
  • COEP Health Care
  • Exchange
  • ONMD Nasdaq
  • COEP Nasdaq
  • Market Cap
  • ONMD 12.8M
  • COEP 27.4M
  • IPO Year
  • ONMD N/A
  • COEP N/A
  • Fundamental
  • Price
  • ONMD $0.55
  • COEP $9.84
  • Analyst Decision
  • ONMD
  • COEP
  • Analyst Count
  • ONMD 0
  • COEP 0
  • Target Price
  • ONMD N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • ONMD 25.4M
  • COEP 37.4K
  • Earning Date
  • ONMD 05-14-2025
  • COEP 08-15-2025
  • Dividend Yield
  • ONMD N/A
  • COEP N/A
  • EPS Growth
  • ONMD N/A
  • COEP N/A
  • EPS
  • ONMD N/A
  • COEP N/A
  • Revenue
  • ONMD $532,000.00
  • COEP $62,874.00
  • Revenue This Year
  • ONMD N/A
  • COEP N/A
  • Revenue Next Year
  • ONMD N/A
  • COEP N/A
  • P/E Ratio
  • ONMD N/A
  • COEP N/A
  • Revenue Growth
  • ONMD N/A
  • COEP N/A
  • 52 Week Low
  • ONMD $0.30
  • COEP $2.31
  • 52 Week High
  • ONMD $1.60
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 54.00
  • COEP 62.24
  • Support Level
  • ONMD $0.53
  • COEP $7.25
  • Resistance Level
  • ONMD $0.63
  • COEP $9.90
  • Average True Range (ATR)
  • ONMD 0.09
  • COEP 0.63
  • MACD
  • ONMD 0.00
  • COEP 0.26
  • Stochastic Oscillator
  • ONMD 12.56
  • COEP 85.62

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: